Skip to main content

Table 2 Tumor characteristics

From: Weight changes according to treatment in a diverse cohort of breast cancer patients

Tumor Characteristics, N (%) All NHPI Asian White Other/Unknown
Stage
 In situ 61 (15.7) 15 (12.7) 25 (18.9) 18 (14) 3 (30)
 Localized 241 (62) 70 (59.3) 80 (60.6) 87 (67.4) 4 (40)
 Regional 87 (22.4) 33 (28) 27 (20.5) 24 (18.6) 3 (30)
Tumor size, mm, mean (SD) 18.7 (14.5) 19.1 (16.8) 18.9 (15.4) 17.7 (11.3) 24.7 (11.9)
Grade
 Well differentiated 78 (20.1) 25 (21.2) 25 (18.9) 28 (21.7) 0
 Moderately differentiated 183 (47) 58 (49.2) 67 (50.8) 55 (42.6) 3 (30)
 Poorly differentiated 90 (23.1) 25 (21.2) 28 (21.2) 34 (26.4) 3 (30)
 Undifferentiated 12 (3.1) 5 (4.2) 3 (2.3) 4 (3.1) 0
 Unknown 26 (6.7) 5 (4.2) 9 (6.8) 8 (6.2) 4 (40)
Lymph node
 Positive 77 (19.8) 31 (26.3) 22 (16.7) 21 (16.3) 3 (30)
 Negative 309 (79.4) 87 (73.7) 107 (81.1) 108 (83.7) 7 (70)
 Unknown 3 (0.8) 0 3 (2.3) 0 0
Estrogen receptor status
 Positive 327 (84) 102 (86.4) 108 (81.8) 109 (84.5) 8 (80)
 Negative 52 (13.4) 13 (11) 19 (14.4) 18 (14) 2 (20)
 Borderline 1 (0.3) 1 (0.9) 0 (0) 0 (0) 0 (0)
 Unknown 9 (2.3) 2 (1.7) 5 (3.8) 2 (1.6) 0 (0)
Progesterone receptor status
 Positive 288 (74) 93 (78.8) 94 (71.1) 94 (72.9) 7 (70)
 Negative 89 (22.9) 23 (19.5) 31 (23.5) 32 (24.8) 3 (30)
 Borderline 2 (0.5) 0 (0) 1 (0.8) 1 (0.8) 0 (0)
 Unknown 10 (2.6) 2 (1.7) 6 (4.6) 2 (1.6) 0 (0)
Her2 status
 Positive 20 (5.1) 3 (2.5) 10 (7.6) 6 (4.7) 1 (10)
 Negative 210 (54) 66 (55.9) 62 (47) 77 (59.7) 5 (50)
 Borderline 2 (0.5) 0 0 2 (1.6) 0 (0)
 Unknown 157 (40.4) 49 (41.5) 60 (45.5) 44 (34.1) 4 (40)